Peter K Kaiser Selected Research

aflibercept

1/2021	Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
1/2020	Twenty-Four-Month OCTA Assessment in Diabetic Patients Undergoing Fixed-Interval Intravitreal Aflibercept Therapy.
1/2020	The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review.
12/2019	Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.
1/2019	Systemic pharmacokinetic/pharmacodynamic analysis of intravitreal aflibercept injection in patients with retinal diseases.
7/2017	Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension Study.
1/2017	Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration.
11/2016	Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
1/2016	Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid.
1/2016	Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter K Kaiser Research Topics

Disease

80	Macular Degeneration (Age-Related Maculopathy) 11/2022 - 03/2003
27	Choroidal Neovascularization 01/2022 - 03/2005
25	Macular Edema 09/2022 - 07/2002
17	Retinal Perforations 07/2022 - 11/2006
13	Endophthalmitis (Ophthalmia) 01/2021 - 01/2003
12	Uveitis 05/2017 - 07/2002
11	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2016 - 07/2007
9	Inflammation (Inflammations) 01/2022 - 12/2004
8	Retinal Vein Occlusion 10/2017 - 06/2005
7	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 12/2010
6	Hemorrhage 01/2019 - 07/2002
5	Wounds and Injuries (Trauma) 01/2017 - 02/2008
4	Retinal Detachment (Retinal Detachments) 02/2010 - 09/2006
3	Central Serous Chorioretinopathy 11/2022 - 01/2015
3	Polypoidal Choroidal Vasculopathy 11/2022 - 05/2013
3	Retinal Vasculitis 01/2022 - 04/2007
3	Retinal Diseases 01/2022 - 01/2019
3	Atrophy 11/2018 - 05/2011
3	Vitreous Detachment (Posterior Vitreous Detachment) 10/2017 - 11/2013
3	Neoplasms (Cancer) 01/2016 - 11/2006
3	Myopia 01/2016 - 03/2003
3	Posterior Uveitis 10/2011 - 10/2008
2	Vitreous Hemorrhage 01/2012 - 11/2007
2	Glaucoma 08/2008 - 10/2007
2	Cataract (Cataracts) 11/2007 - 05/2005
2	Retinitis 06/2007 - 02/2007
2	Ischemia 04/2007 - 11/2006
2	Histoplasmosis 01/2004 - 03/2003
1	Geographic Atrophy 11/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Protein Deficiency 01/2022
1	Blister (Bulla) 12/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021
1	Polyps 01/2020
1	Optic Neuritis (Retrobulbar Neuritis) 01/2016
1	Neuritis (Polyneuritis) 01/2016
1	Ganglion Cysts (Ganglion) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Pseudophakia 06/2013
1	Refractive Errors (Refractive Error) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 11/2012
1	Retinal Neovascularization 01/2012
1	Neovascular Glaucoma 01/2012
1	Melanoma (Melanoma, Malignant) 05/2011

Drug/Important Bio-Agent (IBA)

32	Retinaldehyde (Retinal)IBA 11/2022 - 07/2002
32	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 10/2006
32	Ranibizumab (Lucentis)FDA Link 01/2022 - 10/2006
22	afliberceptIBA 01/2021 - 03/2012
13	Verteporfin (Visudyne)FDA Link 11/2022 - 03/2003
13	Bevacizumab (Avastin)FDA Link 01/2017 - 04/2007
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2022 - 12/2007
6	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 02/2003
6	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 02/2008 - 11/2003
6	SteroidsIBA 10/2007 - 12/2004
5	Triamcinolone (Aristocort)FDA Link 02/2008 - 07/2002
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2007
3	brolucizumabIBA 01/2022 - 01/2021
3	KH902 fusion proteinIBA 01/2020 - 01/2019
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 10/2006
3	microplasminIBA 12/2018 - 03/2014
3	Monoclonal AntibodiesIBA 01/2016 - 10/2006
3	Fluocinolone Acetonide (Capex)FDA LinkGeneric 10/2011 - 02/2007
2	risuteganibIBA 11/2022 - 01/2021
2	Eplerenone (Inspra)FDA LinkGeneric 01/2020 - 01/2015
2	Mineralocorticoid Receptor AntagonistsIBA 01/2020 - 01/2015
2	Ophthalmic Solutions (Eye Drops)IBA 01/2019 - 05/2015
2	Angiogenesis InhibitorsIBA 01/2016 - 10/2006
2	Retinal Pigments (Pigments, Visual)IBA 02/2010 - 06/2007
2	anecortave acetateIBA 01/2007 - 02/2006
1	formycin diphosphate (FDP)IBA 07/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Capsules (Microcapsules)IBA 12/2021
1	regorafenibIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2018
1	Therapeutic UsesIBA 01/2017
1	CollagenIBA 01/2017
1	Vascular Endothelial Growth FactorsIBA 01/2017
1	Endothelial Growth FactorsIBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2016
1	Insulin (Novolin)FDA Link 02/2015
1	pegaptanib (Macugen)FDA Link 11/2012
1	ArgonIBA 01/2012

Therapy/Procedure

32	Therapeutics 01/2022 - 05/2005
15	Vitrectomy 12/2021 - 11/2006
12	Intravitreal Injections 11/2021 - 11/2003
11	Injections 11/2021 - 10/2006
9	Traction 10/2017 - 09/2006
8	Photochemotherapy (Photodynamic Therapy) 05/2012 - 03/2003
7	Lasers (Laser) 12/2018 - 11/2006
7	Light Coagulation 12/2018 - 11/2006
3	Radiotherapy 09/2013 - 06/2009
2	Retreatment 08/2021 - 12/2012
2	Slit Lamp 05/2017 - 08/2016
2	Cataract Extraction 08/2007 - 12/2004
1	Transplantation 12/2021
1	Autologous Transplantation 12/2021
1	Operative Surgical Procedures 07/2014
1	Surgical Instruments (Clip) 01/2014
1	Self-Testing 10/2013
1	Operative Time 06/2013